Targeted Therapeutic Strategies for the Treatment of Cancer

Extensive research is underway to develop new therapeutic strategies to counteract therapy resistance in cancers. This review presents various strategies to achieve this objective. First, we discuss different vectorization platforms capable of releasing drugs in cancer cells. Second, we delve into m...

Full description

Bibliographic Details
Main Authors: Benjamin Victoir, Cécile Croix, Fabrice Gouilleux, Gildas Prié
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/16/2/461
_version_ 1797344433742544896
author Benjamin Victoir
Cécile Croix
Fabrice Gouilleux
Gildas Prié
author_facet Benjamin Victoir
Cécile Croix
Fabrice Gouilleux
Gildas Prié
author_sort Benjamin Victoir
collection DOAJ
description Extensive research is underway to develop new therapeutic strategies to counteract therapy resistance in cancers. This review presents various strategies to achieve this objective. First, we discuss different vectorization platforms capable of releasing drugs in cancer cells. Second, we delve into multitarget therapies using drug combinations and dual anticancer agents. This section will describe examples of multitarget therapies that have been used to treat solid tumors.
first_indexed 2024-03-08T11:02:20Z
format Article
id doaj.art-97b903ae27b74a1297f5b54e1324af79
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-08T11:02:20Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-97b903ae27b74a1297f5b54e1324af792024-01-26T15:39:09ZengMDPI AGCancers2072-66942024-01-0116246110.3390/cancers16020461Targeted Therapeutic Strategies for the Treatment of CancerBenjamin Victoir0Cécile Croix1Fabrice Gouilleux2Gildas Prié3INSERM UMR 1100 CEPR, Equipe “Mécanismes Protéolytiques Dans L’inflammation”, Faculté de Médecine, 10 Boulevard Tonnellé, BP 3223, 37032 Tours Cedex 01, FranceINSERM UMR 1100 CEPR, Equipe “Mécanismes Protéolytiques Dans L’inflammation”, Faculté de Médecine, 10 Boulevard Tonnellé, BP 3223, 37032 Tours Cedex 01, FranceINSERM UMR 1100 CEPR, Equipe “Infection Respiratoire et Immunité”, Faculté de Médecine, 10 Boulevard Tonnellé, BP 3223, 37032 Tours Cedex 01, FranceINSERM UMR 1100 CEPR, Equipe “Mécanismes Protéolytiques Dans L’inflammation”, Faculté de Médecine, 10 Boulevard Tonnellé, BP 3223, 37032 Tours Cedex 01, FranceExtensive research is underway to develop new therapeutic strategies to counteract therapy resistance in cancers. This review presents various strategies to achieve this objective. First, we discuss different vectorization platforms capable of releasing drugs in cancer cells. Second, we delve into multitarget therapies using drug combinations and dual anticancer agents. This section will describe examples of multitarget therapies that have been used to treat solid tumors.https://www.mdpi.com/2072-6694/16/2/461targeted therapiesmultitarget therapiesdrug releasevectorizationdrug combinationsnanocarriers
spellingShingle Benjamin Victoir
Cécile Croix
Fabrice Gouilleux
Gildas Prié
Targeted Therapeutic Strategies for the Treatment of Cancer
Cancers
targeted therapies
multitarget therapies
drug release
vectorization
drug combinations
nanocarriers
title Targeted Therapeutic Strategies for the Treatment of Cancer
title_full Targeted Therapeutic Strategies for the Treatment of Cancer
title_fullStr Targeted Therapeutic Strategies for the Treatment of Cancer
title_full_unstemmed Targeted Therapeutic Strategies for the Treatment of Cancer
title_short Targeted Therapeutic Strategies for the Treatment of Cancer
title_sort targeted therapeutic strategies for the treatment of cancer
topic targeted therapies
multitarget therapies
drug release
vectorization
drug combinations
nanocarriers
url https://www.mdpi.com/2072-6694/16/2/461
work_keys_str_mv AT benjaminvictoir targetedtherapeuticstrategiesforthetreatmentofcancer
AT cecilecroix targetedtherapeuticstrategiesforthetreatmentofcancer
AT fabricegouilleux targetedtherapeuticstrategiesforthetreatmentofcancer
AT gildasprie targetedtherapeuticstrategiesforthetreatmentofcancer